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1 |  INTRODUCTION
Hypertension is a major public health issue among industrial-
ized nations, and several clinical and epidemiological studies 
have shown a clear link between dietary Na+ intake and blood 
pressure. With Na+ and K+ homeostasis being closely inter-
linked, a low Na+ and high K+ diet has been shown to lower 
blood pressure (Mente et al., 2014). Studies on monogenic 
syndromes such as Gordon's (Familial Hyperkalaemia & 
Hypertension, http://omim.org/entry/ 145260) and Gitelman 
(OMIM http://omim.org/entry/ 263800) have shown that mu-
tations in ion channels and transporters and/or their regula-
tors such as WNK proteins in the nephron perturb the Na+/K+ 
homeostasis and cause significant changes in blood pressure. 
The distribution of these proteins along the nephron reflects 
the key importance of these nephron segments including the 
loop of Henlé (LoH), the distal convoluted tubule (DCT), and 
the contiguous segments of the connecting tubule (CNT) and 
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Abstract
A potassium (K+) rich diet is known to have an antihypertensive effect that has been 
embodied by the NHLBI in the DASH diet. However, the molecular basis for this 
blood pressure‐lowering effect has been unclear, until a recent study proposed a 
model in which the DCT cells of the kidney regulate their salt transport in response to 
variations in intracellular chloride ([Cl−]i), which are directly regulated by serum K+. 
With the knowledge that WNK proteins are Cl− sensors, and are a part of the WNK/
SPAK/NCC signaling cascade which regulates the NCC, the main salt transporter in 
the distal nephron, we examined the effect of serum K+ on the ([Cl−]i) and, in turn its 
effect on the WNK4 signaling pathway in a “modified HEK 293T” cell line. Using a 
fluorescence‐based approach in this cell line, we have shown that the membrane po-
tential of the cell membrane is sensitive to the small changes in external KCl within 
the physiological range (2–5 mM), thus functioning as a K+ electrode. When the 
extracellular K+ was progressively increased (2–5 mM), the membrane depolariza-
tion lead to a subsequent increase in [Cl−]i measured by fluorescence quenching of an 
intracellular chloride sensor. Increase in extracellular [K] resulted in a decrease in the 
phosphorylation of the WNK4 protein and its downstream targets, SPAK and NCC. 
This confirms that small changes in serum K can affect WNK4/SPAK/NCC signal-
ing and transcellular Na+ flux through the DCT and provide a possible mechanism 
by which a K‐rich DASH diet could reduce blood pressure.
K E Y W O R D S
chloride sensing domain, NCC, potassium, SPAK kinase, WNK kinases
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collecting duct (CD) in the homeostatic process. The WNK/
SPAK pathway regulates various ion transporters/channels in 
this segment of the nephron, and thus WNK kinase expres-
sion and activity is pivotal. In the DCT, WNKs are activated 
by sympathetic stimulation, cortisol, (Terker et al., 2014) low 
extracellular K+, (Terker et al., 2015) and low intracellular 
Cl− (Piala et al., 2014; Terker, Zhang, et al., 2016), which 
affect its phosphorylation state that in turn leads to an activa-
tion of downstream targets. WNK kinases phosphorylate and 
activate SPAK (STE20/SPS1‐related proline‐alanine‐rich 
protein kinase) and OSR1 (Oxidative Stress Responsive 1), 
which in turn bring about the coordinated phosphorylation of 
NCC and NKCC2 in the DCT and TAL of the nephron, re-
spectively (Richardson & Alessi, 2008; Vitari et al., 2006). In 
the DCT, the WNKs are degraded by the proteasome pathway 
when they are targeted by a kelch‐like protein 3 (KLHL3) 
mediated ubiquitylation by Cullin3 (Cul3) (Ohta et al., 2013; 
Schumacher et al., 2015).
Studies on the WNK/SPAK/NCC signaling pathway 
have elucidated the molecular link between WNK kinases 
and the regulation of blood pressure by their effect on renal 
electrolyte homeostasis, and how the aldosterone regu-
lated the processes of Na+ absorption (from the urine to 
the blood) and K+ secretion (from the blood to the urine) 
work in concert in the distal nephron (Kahle et al., 2003). 
Although the benefits of a high‐K diet in lowering blood 
pressure has been well‐established, only the recent find-
ing that WNK kinases are chloride‐sensitive has provided 
a clue to the molecular basis for this effect (Ellison & 
Terker, 2015). WNK kinases switch between active and 
inactive states based on their phosphorylation status, with 
phosphorylation stabilizing the active state. Cl− ions sta-
bilize the inactive WNK1, and this prevents any kinase 
autophosphorylation and activation, thus explaining how 
the changes in intracellular chloride and tonicity affect the 
WNK kinase activity (Piala et al., 2014). This activation 
is rapid, occurring in less than 0.5 min, and is due to the 
phosphorylation of the serine residue in the T‐loop which 
is conserved across all the WNKs. Crystallographic data on 
WNK1 have shown that it has an “LGL” motif, also called 
a “chloride sensor,” that confers chloride sensitivity by 
blocking the autophosphorylation of the T‐loop, and thus 
confirming that WNKs are the key chloride sensing kinases 
which regulate the behavior of Na+ and K+ cation cotrans-
porters such as NCC and NKCC2 (Haas & Forbush, 2000). 
Mutating the leucine residue in the LGL motif (LL to FF) 
causes an activation of WNK kinase function which is most 
pronounced in WNK4 (Piala et al., 2014). Recently, Ellison 
has proposed a model for DCT function in which low ex-
ternal K+ ([K+]o) causes the DCT cell to hyperpolarize, 
resulting in the efflux of Cl−, a reduction in [Cl−]i and acti-
vation of the WNK/SPAK/NCC pathway. With high [K+]o, 
the contrary occurs–the DCT is depolarized, Cl− enters the 
cell and the rise in [Cl−]i deactivates the WNK4/SPAK/
NCC pathway (Terker et al., 2015). Thus the level of Na+ 
reabsorption at the DCT is directly regulated by the [K+]o, 
which determines the phosphorylation state of NCC by 
controlling the activity of the WNK/SPAK/NCC pathway.
We have tested the Ellison model directly to show that the 
effect of plasma [K+] on NCC levels is mediated by changes 
in [Cl−]i, in response to changes in the membrane potential 
(Vm) of the cell. To do this, we have used an in vitro sys-
tem, that is, modified HEK‐293T cells generated by tran-
sient transfection of the necessary ion channels/transporters, 
including KCNJ10, Clc‐kb, Barttin, typically found in DCT 
cells. A fluorescence‐based approach was used to directly 
show that increasing [K+]o depolarizes the cells and causes 
subsequent inactivation of the WNK/SPAK/NCC cascade.
2 |  MATERIALS AND METHODS
2.1 | Cell culture and transfection
Human embryonic kidney HEK‐293 T cells were cultured 
in DMEM high glucose supplemented with 10% (v/v) fetal 
bovine serum, 2  mM L‐glutamine, 100  units/ml penicillin, 
and 0.1 mg/ml streptomycin at 37°C in 5% CO2–95% air at-
mosphere. For transfection experiments, cells were grown 
on 10  mm petri dishes and were incubated for a period of 
36 hr with a mixture of 20 μL of 1 mg/ml polyethylenimine 
(Polysciences) and 5–10 μg of the respective plasmid DNA 
(KCNJ10, Clc‐kb, and barttin from Origene), as described 
(Durocher, Perret, & Kamen, 2002). Depending on whether 
the Vm or [Cl−]i was going to be measured in the cells, the 
plasmid constructs pcDNA3.1 (−) VSFP3.1 (Addgene) or 
pcDNA3.1 (+) EYFP H148Q/I152L (Addgene) were trans-
fected into the cells. Transfected cells were then transferred 
to poly‐L‐lysine coated 96‐well, black microplates (Greiner 
bio‐one), and allowed to adhere overnight before use. 
Simultaneous measurements of both Vm and [Cl−]i in cells by 
co‐expression of the voltage and Cl sensor were not feasible 
because of the large overlap of the two emission spectra of 
CFP and EYFP.
2.2 | Measurement of Vm, and [Cl−]i 
using the Flex station microplate reader
HEK cells transfected with the K+ channel KCNJ10, and the 
voltage‐sensitive dye VSFP3.1 (encoded by pcDNA3.1 (−), 
Addgene) were used to measure the change in Vm at an ab-
sorption and emission wavelengths of 444 and 535 nm, re-
spectively. HEK cells transfected with the chloride sensor, 
pcDNA3.1 (+) EYFP H148Q/I152L (Addgene), KCNJ10, 
Clc‐kb and barttin were used to measure the change in 
[Cl−]i at an absorption and emission wavelengths of 485 and 
555 nm, respectively.
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Immediately before the Flex station measurements, 96‐
well plates with the adhered HEK cells were washed with a 
solution containing 130 mM NaCl, 10 mM NaI, 2 mM KCl, 
2 mM CaCl2, 1 mM MgCl2, and 20 mM HEPES pH 7.3. The 
cells were then incubated in 100 µl of the same solution at 
37°C for 45  min and the fluorescence was measured in a 
FlexStation 3 microplate reader (Molecular Devices) at 2  s 
intervals for 200 s. NaCI was included only in the solutions 
which were used for [Cl−]i measurement. Solutions with dif-
ferent external KCl concentrations were introduced to the 
cells in each well after 50s of baseline measurement (the 
concentration of NaCl was adjusted in each case to maintain 
the osmolality of the solution). Appropriate negative con-
trols were employed, and selective blockers including DIDS 
(Sigma) (L'Hoste et al., 2013), Valsartan (Sigma) (Imbrici 
et al., 2017), Tertiapin Q (Abcam) (Doupnik, 2017), and Ba 
(Sigma) were used as indicated. The change in fluorescence 
(ΔF) was defined as Fmax (peak fluorescence) – Fmin (base-
line fluorescence). EC50 values were obtained by fitting data 
to four‐variable concentration–response curves using Prism 5 
(GraphPad Software Inc., San Diego, CA).
2.3 | Biochemcial studies
HEK‐293 T cells were grown in normal cell culture condi-
tions, and then transfected with mouse NCC (pECFP‐C1‐
NCC) alone, or with WNK4 WT, WNK4 L322F L324F mutant 
or the WNK4 LLFF kinase‐dead mutant form respectively 
(in pMO‐Myc vector, a generous gift from Prof D. Ellison, 
University of Oregon), and grown in medium with different 
external KCl concentrations (2–5 mM).
2.4 | Biotinylation
Transfected HEK 293T cells in 10  cm plates were bioti-
nylated following a previously published method (Murthy, 
Kurz, & O'Shaughnessy, 2016) Briefly, HEK 293T cells in 
10 cm plates were washed once in NES buffer and placed on 
ice. Cells were incubated in 0.2 mg/ml NHS‐ biotin (www.
therm ofish er.com) for 45 min on ice before quenching with 
Tris buffer (25 mM Tris‐HCl; 150 mM NaCl; 10 mM EDTA, 
pH 7.4). Cells were removed from the plate and centrifuged 
at 200g for 5  min at 4°C. Supernatant was discarded and 
cells were incubated in solubilization buffer (25  mM Tris‐
HCl; 150 mM NaCl; 10 mM EDTA; 1% Triton X‐100, pH 
7.4) with protease inhibitors (www.roche.co.uk) at 4°C with 
agitation for 1 hr. The resulting lysate was cleared by cen-
trifugation at 14 K  rpm 4°C for 1 hr. Thirty microliters of 
streptavidin beads (www.therm ofish er.com) per sample were 
washed once in wash buffer (25  mM Tris‐HCl; 150  mM 
NaCl; 10 mM EDTA; 1% Triton X‐100, pH 7.4), centrifuged 
at 1,400 rpm for 5 min at 4°C and supernatant removed. The 
supernatant was added to streptavidin beads and incubated 
with agitation for 2 hr at 4°C. Beads were then pelleted at 
14K rpm for 5 min at 4°C and washed three times in wash 
buffer before resuspending the pellet in 4× sample buffer 
(www.lifet echno logies.com) for Western blotting.
2.5 | Western blotting
For blots with nonbiotinylated cell lysates, cells were har-
vested 36 hr post‐plasmid transfection from the 10 cm plates, 
and lysed in 300 µl lysis buffer (Terker, Zhang, et al., 2016) 
(supplemented with protease inhibitors, phosphatase in-
hibitors, and 1  mM DTT). After protein quantification by 
Bradford's method, 20 µg equivalent total protein lysate was 
loaded on to 3%–8% Tris‐acetate Nupage gel and transferred 
to nitrocellulose membranes. Membranes were Ponceau 
stained to check for transfer efficiency and loading, then 
blocked with 5% milk for 1 hr and incubated with primary 
antibody in 5% (w/v) skimmed milk in TBS‐T with the in-
dicated primary antibodies: 1 in 500 diluted rabbit phos-
pho‐WNK4 Ser575 antibody (a generous gift from Prof Isao 
Naguro, Japan) or 2 µg/ml sheep phospho‐SPAK Thr373 an-
tibody and peptide (to prevent binding to nonphosphorylated 
SPAK (10 µg/ml) (Division of Signal Transduction Therapy 
Unit, University of Dundee) or pNCC Thr58 (a generous gift 
from Prof J Loffing, University of Zurich) (1 in 1,000 dilu-
tion) overnight at 4°C. β‐actin (mouse antibody from Thermo 
Fisher, 1 in 2,000 dilution) was stained as a loading control. 
The blots were then washed three times with TBS‐T and in-
cubated in secondary antibodies, donkey anti rabbit 800CW 
(926–32213 at 1:5,000 dilution; www.licor.com), and goat 
anti mouse Alexa680 (A‐21058 at 1:5,000 dilution; www.
lifet echno logies.com) in TBS‐Tween 20 for 1 hr at room tem-
perature in the dark and then washed six times in TBS‐Tween 
20. Membranes were imaged using the LiCor Odyssey sys-
tem (www.licor.com), and the blots were quantified using the 
Image studio Lite software www.licor.com).
2.6 | Statistical analysis
All data are shown as mean ± SEM unless indicated other-
wise. Significance was determined using unpaired t test or 
one‐way ANOVA followed by post hoc testing as appropri-
ate. p  <  .05 was considered significant. The stats package 
in Prism4 (http://www.graph pad.com/scien tific-softw are/
prism/ ) was used.
3 |  RESULTS
3.1 | Measurement of change in membrane 
potential (Vm)
Cells transfected with the voltage‐sensitive VSFP3.1 exhib-
ited a typical CFP (cyan fluorescent protein, emission max at 
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535 nm) emission spectrum that was sensitive to membrane 
depolarization when the [KCl]o was changed progressively 
from 2 through 5 mM KCl (Figure 1a). This effect of increase 
in external K+ resulted from increasing quenching of the 
CFP fluorescence (Figure 1a) over the range of [KCl]o used, 
the normalized change in fluorescence (ΔF/Fo) exhibited a 
log‐linear relationship with increasing external KCl (Figure 
1b), showing that the membrane functions as a K+ electrode. 
The fluorescence quenching in 5  mM [KCl]o was affected 
by the presence of the K channel blockers Ba2+ or Tertiapin 
Q (Figure 1c); Ba2+ abolished the quenching almost com-
pletely, while Tertiapin Q (50nM)`reduced it to about 10%. 
The quenching response to increasing external KCl was not 
observed in cells, which were not transfected with KCNJ10 
(data not shown).
3.2 | I‐ affects basal YFP quench
YFP, a genetically modified variant of green fluorescent 
protein (GFP), is halide sensitive, and the H148Q/I152L 
mutant form of YFP has increased sensitivity to halides 
with the relative affinity of anions to YFP‐H148Q/I152L 
being I−>NO3−>Br−> Cl− (Galietta, Haggie, & Verkman, 
2001). About 10 mM NaI was used in all our experimen-
tal solutions, based on previous work with this fluorophore 
(Johansson, Norris, & Peilot‐Sjogren, 2013) showing that 
10 mM NaI was an optimal concentration for assay perfor-
mance while ensuring that there is no artifact of agonist‐
independent I‐ permeability of the cells. EYFP quenching 
was not observed when cells were assayed in the absence 
of I‐ (data not shown).
3.3 | Changing external [KCl] affects EYFP 
fluorescence in the cells
HEK cells expressing YFP‐H148Q/I152L showed a step‐wise 
fluorescence quenching in response to increasing [KCl]o. A 
maximal EYFP fluorescence quenching of over 50% was 
seen when the concentration of KCl was stepped up from 2 to 
5 mM, a physiologically relevant range of [K+]o (Figure 2a). 
When the normalized change in fluorescence (ΔF/Fo) was 
plotted against [K+]o, the data fitted a four‐variable dose–
response curve, with an IC50 of 2.9 mM KCl (Figure 2b). 
The quenching response to increasing external KCl was not 
F I G U R E  1  HEK cells transfected with VSFP3.1 and KCNJ10 were exposed to different [KCl]o. Fluorescence at 2 mM KCl recorded from 
1 to 200 s was adjusted to a baseline of 100%. For those wells where [KCl]o was changed, a baseline was obtained for the first 50 s in 2 mM 
KCl, after which the [KCl]o was increased from 2 through 5 mM KCl in 0.5 mM steps, respectively (a). CFP quenching at different [KCl]o. (b) 
Normalized response to KCl (ΔF/Fo) plotted semilogarithmically against final [K]o. Data points are means of triplicates. (c) Effect of K channel 
blockers on CFP quenching
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observed in cells which were not transfected with Clc‐kb and 
barttin (data not shown).
In the presence of the Cl channel blockers, the fluores-
cence quenching was substantially reduced. DIDS (4,4′‐
Diisothiocyanatostilbene‐2,2=‐ disulfonic acid), an inhibitor 
of Cl− flux (Wulff, 2008), abolished the EYFP quenching 
almost completely, suggesting that the K effect on Cl− in-
flux and intracellular EYFP depends on the expressed Clc‐kb 
channel, whereas Valsartan (Imbrici et al., 2017) was less ef-
fective in comparison to DIDS. Tertiapin Q also reduced the 
EYFP quenching by about 50%, suggesting that K+ influx 
into the cells through KCNJ10 was necessary for the subse-
quent Cl− influx, and EYFP quenching (Figure 2c).
3.4 | Extracellular KCl affects 
phosphorylated WNK4 (pWNK4) levels in 
NCC and WNK4 transfected cells
Having observed the sensitivity of the “model HEK cell” 
membrane to coupled changes in [KCl]o and transmembrane 
Cl− movement, the consequence for the cellular WNK4/
SPAK/NCC signaling pathway was investigated. Altering 
[KCl]o had distinct effects on the phosphorylation status of 
the different forms of WNK4 in the transfected cells. WNK4 
WT was affected inversely with pWNK4 levels falling (Figure 
3a) when [KCl]o was increased from 2 to 3 mM and above. 
A steep fall in pWNK4 levels was observed upon changing 
the [KCl]o from 2 to 3 mM with a further small reduction 
in its levels between 3 and 5 mM KCl (Figure 3b). The K 
channel blocke,r Tertiapin Q, abolished this effect on WNK4 
WT levels (Figure 3c), demonstrating the role of the KCNJ10 
channel in mediating the effect of changing [K+]o on WNK4 
levels. Increasing [K+]o did not affect the intensities of the 
Cl insensitive mutant WNK4 LLFF (Figure 3d), confirming 
the role of the Cl binding domain of WNK4. Finally replac-
ing WT WNK4 with the WNK4 LF kinase‐dead markedly 
reduced or abolished p WNK4 levels showing the importance 
of the kinase domain for the changes seen in pWNK4.
3.5 | Increase in external KCl affects the 
downstream phosphorylation targets of WNK4
The inverse relationship between [KCl]o and pWNK4 lev-
els was reflected in its downstream phosphorylation targets: 
F I G U R E  2  HEK cells transfected with EYFP H148Q/I152L, KCNJ10, Clc‐kb, and barttin and exposed to different [KCl]o. Fluorescence at 
2 mM KCl recorded from 1 to 200 s was adjusted to a baseline of 100%. For those wells where [KCl]o was changed, a baseline was obtained for the 
first 50 s in 2 mM KCl, after which the [KCl]o was increased from 2 mM through 5 mM KCl, respectively. (a) EYFP quenching at different [KCl]o. 
(b) Normalized response to KCl (ΔF/Fo) plotted against final [Ko]. Data points are means of four different experiments. (c) Effect of different 
channel blockers, such as Ba2+ (1 mM), Tertiapin Q (100 nM), Valsartan (100 µM), DIDS (200 µM) on EYFP quenching
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SPAK and NCC. Both pSPAK (Figure 4a) and pNCC 
(Figure 4c) levels decreased with increasing [KCl]o in 
the model HEK cells expressing WNK4 WT. This fall in 
pSPAK levels with an increase in [KCl]o from 2 to 5 mM 
(Figure 4b) possibly explains the decline in the phosphoryl-
ation of NCC at a similar range of concentrations of [KCl]o. 
The levels of pNCC is a linear function of [KCl]o within 
the range of 2 to 5  mM, and the slope of the trendline is 
comparable (Figure 4d) to the one observed when the pNCC 
levels were plotted against a similar range of plasma [K+] 
(in the mice untreated with aldosterone) in the in vivo study 
(Terker, Zhang, et al., 2016). With pNCC being a marker 
for NCC activity (Pacheco‐Alvarez et al., 2006), the effect 
of [KCl]o on pNCC suggests that the NaCl entry via NCC 
would be reduced at physiologically viable higher [K+]o due 
to its restricted activity.
4 |  DISCUSSION
Although K+ is the most abundant exchangeable cation 
in the human body, with an intracellular concentration of 
140–150 mM, the serum [K] is normally maintained within 
a smaller physiological range, 3.5–5  mM. Earlier animal 
studies have shown that a large increase in dietary K+ af-
fects the abundance and activity of the cotransporter NCC 
(Terker et al., 2015; Vitzthum et al., 2014); however, a recent 
paper (Terker, Zhang, et al., 2016) has demonstrated that K+ 
is a pivotal modulator of NCC at a physiologically relevant 
concentration, and proposed a possible mechanism (“Ellison 
hypothesis”) to explain this. Our in vitro study is a work-
ing model of this hypothesis, where the physiological and 
molecular effects of changing [K+]o on intracellular Cl and 
the WNK/SPAK/NCC pathway (involved in regulating salt 
transport across the DCT) has been shown in a “DCT‐like” 
HEK cell system.
Using a CFP fluorescence‐based approach in the model 
HEK cell system, we have shown that the cell membrane 
functions as a K+ electrode which responds to small, step‐
wise changes of 1 mM KCl when the [K+]o is increased from 
2 mM through 5 mM in cells expressing KCNJ10. Significant 
reduction in EYFP fluorescence was detected as [KCl]o 
was increased, indicating an inverse relation of EYFP flu-
orescence quenching to increased [K+]o. Blockers such as 
Tertiapin Q and BaCl2 abolished these effects of changing 
[K+]o, demonstrating the role of the K channels on the DCT‐
like cell membrane (including KCNJ10), whereas the ClC 
channel blockers affected EYFP quenching which is a con-
sequence of Cl− influx across the membrane, and binding 
of these anions to the EYFP protein. Thus our model cells 
mimics the hypothesized behavior of DCT cells and confirms 
they can respond to small changes in [K+]o within the phys-
iological range followed by transmembrane anion transport 
through ClCs.
The model HEK cells expressing WNK4 or its mutant 
forms respectively responded differently to altering [K+]o in 
the physiologically relevant range of 2 to 5 mM. The [K]o 
affected the activity of WNK4/SPAK/NCC signaling and 
its downstream targets in this model cell line as determined 
by measuring the levels of pWNK4, pSPAK, and pNCC 
level, respectively. The inverse effect of increasing [K+]o 
on pWNK4 levels in cells expressing wild‐type WNK4 was 
abolished by K channel blockers (tertiapin and Ba2+), thus 
confirming that DCT K channels (such as KCNJ10) are the 
route for K entry into these cells, which facilitates the sub-
sequent effects on the WNK4/SPAK/NCC pathway as ob-
served in in vivo studies (Wang et al., 2018). The absence 
of a similar K+ sensitivity to the phosphorylation states of 
the same proteins in cells expressing the Cl− insensitive mu-
tants, WNK4 LLFF and WNK4 LF KD respectively, empha-
sises the importance of the WNK4 Cl− binding and kinase 
domains for transducing the membrane potential changes 
caused by altered [K+]o.
WNK4 has been shown to be the most responsive WNK 
family member to changes in [Cl−] (Terker, Zhang, et al., 
2016), so it appears to be the key sensor of [K+] in DCT 
cells where [Cl−]i is typically around 10–20 mM (Weinstein, 
2005). Our model HEK cells behave like the DCT cells, with 
the downstream signaling targets of WNK4, the SPAK and 
NCC showing a corresponding decrease in their phosphor-
ylation levels at [K+]o of 5 mM. Although WNK1 has been 
reported to be the [K+] sensor in HEK cells (Terker et al., 
2015) (due to its higher [Cl−]i of >40 mM), the exogenously 
expressed WNK4 in our model cell probably functions as 
the primary sensor due to its much greater abundance over 
WNK1.
The abundance of both pSPAK and pNCC in our in vitro 
study showed an inverse relationship to the increase in [K]o, 
and interestingly, the pattern of pNCC reduction with [K]o 
was comparable to the one observed in aldosterone untreated 
F I G U R E  3  Effect of [K]o on WNK4 phosphorylation in HEK 293 T cells transfected with NCC alone or different forms of WNK4: WNK4 
WT, WNK4 LLFF, and WNK4 LLFF KD, respectively. (a) Total protein lysates were blotted from HEK 293 T cells transfected with NCC and the 
WT WNK4 at four different external KCl. Rabbit phospho WNK4 Ser 575 antibody detected a 150 KDa WNK4 band. ß‐actin was the loading 
control. This is representative of Western blots replicated three times with cell lysates from three different passage numbers. (b) Quantification of 
Western blots showing phospho WNK4 levels normalized to its ß‐actin loading control. Error bars represent mean ± SEM of Western blots (n = 3). 
*p < .0001 by two‐tailed t test. (c) The effect of K channel blocker, Tertiapin Q on phospho WNK4 levels at 4 mM, and 5 mM KCl, respectively. 
(d) Phospho WNK4 levels in cells transfected with the three different WNK4 forms, and at four, different [K]o
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F I G U R E  4  Effect of [K]o on NCC phosphorylation in HEK 293 T cells transfected with NCC alone or with WNK4 WT. The transfected cells 
were treated with external KCl concentrations of 2, 3, 4, and 5 mM respectively. Cells were biotinylated. (a) Nonbiotinylated fraction of the cell 
lysates were blotted. Sheep pSPAK t373 antibody detected an approximately 60 KD band. (b) Quantification of Western blots showing phospho 
pSPAK levels normalized to its ß‐actin loading control. Error bars represent mean ± SEM of Western blots (n = 3). p < .05 by one‐way ANOVA. 
(c) Biotinylated protein lysates were blotted and rabbit pNCC Thr 58 antibody detected a 150 KDa phospho NCC band. (d) Quantification of 
Western blots showing biotinylated phospho NCC levels. Error bars represent mean ± SEM of Western blots (n = 3). *p < .05 by two‐tailed t test
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mice in in vivo. However, in the same study aldosterone‐
treated mice showed a much steeper decline in pNCC abun-
dance with an increase in plasma [K+] (Terker, Zhang, et al., 
2016), suggesting a role for aldosterone in ameliorating the 
phosphorylation and thus activation of NCC at low plasma 
[K+].
Given NCC is the principal transporter for Na+ reab-
sorption in the DCT, it plays a crucial role in controlling 
blood pressure, and has been shown to be regulated by 
the hormone aldosterone indirectly via changes in plasma 
[K+] (van der Lubbe et al., 2012; Terker, Yarbrough, et al., 
2016). Interestingly, a recent study revealed that aldoste-
rone rapidly activates NCC, and that this effect is lost at 
high [K+] in ex vivo experiments. A membrane bound G 
protein‐coupled receptor, GPR30, mediated the effect of 
aldosterone on NCC in both the in vivo and ex vivo stud-
ies, and phosphoproteomics in combination with network 
analysis and further in vitro work showed the activation of 
the EGFR tyrosine kinase pathway by aldosterone through 
GPR30. Thus our understanding of the signaling pathways 
regulating NCC are increasingly detailed (Cheng et al., 
2019). We have not investigated the aldosterone effects in 
our DCT‐like HEK cells, but this is an important avenue 
for further work. Our modified HEK cell system could 
function as a potential model to study other aspects of NCC 
regulation.
Considerable work has gone into the elucidation of NCC 
phosphorylation by the WNK/SPAK pathway whereas the 
molecular mechanisms controlling the dephosphorylation 
of NCC are still poorly understood. In one of our earlier in 
vitro studies in Xenopus oocytes, NCC activity was found 
to be regulated by Protein phosphatase 4 (PP4) through its 
interaction with a conserved N‐terminal amino acid thre-
onine 58 of NCC, and this regulation was independent 
of WNK4 regulated NCC trafficking to the membrane 
(Glover, Mercier Zuber, Figg, & O'Shaughnessy, 2010). 
More recently, signaling pathways independent of the 
WNK4/SPAK cascade have been shown to regulate NCC 
phosphorylation (and therefore its activity) in the DCT 
(Penton et al., 2019). In vitro studies showed that protein 
phosphatase 1 (PP1) dephosphorylates NCC whereas the 
PP1 inhibitor calyculin A had the opposite effect, and pro-
tein kinase A (PKA)‐dependent phosphorylation of the PP1 
inhibitor 1 abolished the PP1‐mediated dephosphorylation 
of NCC in ex vivo mouse kidney preparations (Penton et 
al., 2019). A comprehensive study of PP inhibitors in our 
cells has not been done to confirm if either PP1 or PP4 
are important controllers of NCC dephosphorylation in our 
model HEK cells.
The calmodulin and calcineurin cascade has been shown 
to mediate NCC dephosphorylation after acute K+ loading, 
and this is independent of the anion (Shoda et al., 2017). 
It would be of interest to investigate the potential signaling 
pathways regulating NCC dephosphorylation which operate 
at physiologically relevant [K+], and we are using a proteom-
ics approach in order to discover them.
In summary, we have shown using fluorescence‐based sen-
sors that HEK cells expressing KCNJ10, Clc‐kb, and barttin 
are highly sensitive to changes in [K+]o within the physiologi-
cal range and also show the changes in intracellular [Cl−] that 
affect downstream WNK4/SPAK/NCC signaling. This con-
firms the hypothesized DCT model in which the transcellular 
flux of NaCl in the DCT is directly regulated by the membrane 
potential of the DCT cell and its direct coupling to the phos-
phorylation state of NCC through the Cl− sensor WNK4.
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